CERS Q2 2018 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$335M

Q2 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$15M+61.9% YoY

Gross Profit

$8M49.9% margin

Operating Income

-$13M-81.5% margin

Net Income

-$13M-86.1% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+13.7%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$152M

Total Liabilities

$61M

Stockholders' Equity

$90M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$10M	+61.9%
Gross Profit	$8M	$5M	+49.1%
Operating Income	-$13M	-$16M	+22.4%
Net Income	-$13M	-$17M	+22.3%

Revenue Segments

Product

$15M79%

Government Contract

$4M21%

Geographic Segments

Europe Middle East And Africa

$12M78%

North America

$3M20%

Other

$253,0002%